...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30, 2019

Free
AGORACOM NEWS FLASH

BREAKING: Gratomic Signs Deal to Supply Graphite to Todaq

  • Signed an agreement with Todaq Star Program Phase 1 Corp. to supply Todaq with an aggregate of US$25,000,000 of graphite from its Aukam project in Namibia over approximately 39 months
  • Initial order will be for 600 tonnes of graphite valued at US$3,000,000 payable in TODA Notes, a digital asset created as a medium for exchange and store of value, at a price of US$0.10 per TDN for an aggregate of 30 million TDN
  • Initial 600 tonnes of graphite are to be delivered within 90 days
  • Graphite is being purchased by Todaq to sit in reserve as a backstop to underpin the value of deployed TDN

Gratomic large new

Hub On AGORACOM / Read Release

Message: 2019 Potential Events

In addition to the 2019 potential events list, here are some key dates focusing on the next four months with a focus on the build up to ASN and AHA in November. Four months from today, both ASN and AHA will be wrapped up and this story will be several chapters ahead of where we are now. Get your popcorn ready.

By end of July: MD&A and Financials posted

August 14th: Submission deadline for AHA 2019 Late Breaking Clinical Trial abstracts (regular abstract deadline was June 6th). 

August 16-31: Submission deadline for CTAD Asia Late Breaking abstracts (regular abstract deadline was July 2).

August 31-Sept 4: ESC 2019 incuding 2 posters and a symposium. See here for details.

September 4: Submission deadline for ASN Kidney Week 2019 Late Breaking Clinical Trial abstracts (regular abstract deadline was May 30th).

Sept 16-20: EASD 2019 conference including one poster. See here for details.

Sometime in September: BETonMACE database lock. From the July 8 news release "currently projected for within September 2019.

Sometime mid-September to mid-October: BETonMACE top-line data. From the July 8th news release "Approximately two weeks after DBL......top-line results (i.e. primary and selected secondary endpoints) are expected to be announced."

Mid- to Late-September: AHA Announces Late Breaking Clinical Trial schedule and non-late breaking science titles listed in AHA 2019 program planner.  

Sometime September to November: It is possible that a BETonMACE trial design and rationale paper is published around this time. IR previously advised me that it was a goal to get this published before top-line.

October 11: Titles of accepted ASN Kidney Week Late Breaking Clinical Trials will be posted online. Accepted ASN Kidney Week regular abstracts will also be posted online.

October 11-12: CTAD Asia. Unsure when agenda/schedule will be posted. Probably September. 

November 5: Regular abstracts for AHA 2019 will be available online 5am ET. Late Breaking abstracts and presentations are embargoed until the day and time of presentation and no information may be released before then.

Nov 6-10: ASN Kidney Week Conference, during which some BETonMACE data might be presented and simultaneously published. Since ASN happens before AHA, not sure what to expect for MACE vs. Renal/CKD data. Possible that BETonMACE full data presented and published during this conference.

Nov 11-13: BIO-Europe. Presentation schedule not posted yet. Talk about great timing for a high-impact BIO-Europe. Smack in the middle of ASN and AHA.

November 16th-18th, 2019: AHA 2019 Conference, during which some BETonMACE data might be presented and simultaneously published. Since ASN happens before AHA, not sure what to expect for MACE vs. Renal/CKD data. Possible that BETonMACE full data presented and published during this conference.

 

Share
New Message
Please login to post a reply